AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Fusion Pharmaceuticals To Present at The 38th Annual J.P. Morgan Healthcare Conference

January 10, 2020 GMT

HAMILTON, Ontario & BOSTON--(BUSINESS WIRE)--Jan 10, 2020--

Fusion Pharmaceuticals Inc., a privately-held, clinical-stage precision oncology company developing next-generation radiopharmaceuticals, today announced that Chief Executive Officer John Valliant, Ph.D., will present an overview of the Company at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The presentation will take place on Thursday, January 16, 2020 at 11:00am PST.

About Fusion Pharmaceuticals, Inc.

Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted alpha therapeutics to treat cancer. Using its proprietary Fast-Clear™ Linker Technology platform, Fusion attaches medical isotopes to targeting molecules creating novel, next-generation cancer treatments. In preclinical studies, the Company has shown the ability to precisely target and effectively kill solid tumor cells while minimizing the impact to healthy tissue. Fusion’s lead program, FPI-1434, is currently in a Phase 1 trial.

With a proprietary discovery platform, Fusion is actively in-licensing targeting molecules and forming strategic partnerships to expand its pipeline of cancer therapies. For more information, please visit www.fusionpharma.com or contact info@fusionpharma.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200110005309/en/

CONTACT: Amanda Cray

Senior Director of Investor Relations & Corporate Communications

617-420-5698

cray@fusionpharma.com 

KEYWORD: UNITED STATES NORTH AMERICA CANADA CALIFORNIA MASSACHUSETTS

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS

SOURCE: Fusion Pharmaceuticals Inc.

Copyright Business Wire 2020.

PUB: 01/10/2020 09:30 AM/DISC: 01/10/2020 09:30 AM

http://www.businesswire.com/news/home/20200110005309/en